Loading...

Pheton Holdings Ltd Class A Ordinary Shares

PTHLNASDAQ
Healthcare
Medical - Devices
$29.15
$0.73(2.57%)

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Company Profile & Overview

Explore Pheton Holdings Ltd Class A Ordinary Shares’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Company Profile & Overview

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

SectorHealthcare
IndustryMedical - Devices
CEOJianfei Zhang

Contact Information

86 10 8481 7665
NET Building, Beijing

Company Facts

10 Employees
CountryCN
Actively Trading

Frequently Asked Questions

;